Decentralize Research with Flexibility

Right-size how your protocol is decentralized with our flexible, modular digital and DCT platform

Digital Screening:
Recruit Patients at Home

Enable remote screening at scale, globally
Meet your studies enrollment targets faster
Develop any screening assessment
Learn More

Teleconsent:
Flexible Remote Informed Consent

Improve consent readability with responsive layouts on web, mobile, & more
Deliver remote eConsent to patients on par with consumer digital experiences
Accommodate local regulations and languages with global flexibility
Learn More

TeleVisit:
Bring on-site experiences home

Engage patients and remove the burden of time and travel of an on-site visit
Improve patient access and engagement
Streamline communication with a safe and compliant Trial-Fit Telemedicine solution
Learn More

TeleCOA:
Clinical Outcome Assessments Anywhere

Right size your COA strategy
Capture outcome assessments remotely
Deploy diaries, ePROs, and more rapidly
Learn More
We know now that when patients are able to access a clinical trial online, using telemedicine and remote consent, most clinical trials will enroll three times faster. That’s an incredible data point that we didn’t know before COVID-19.
Dr. Michelle Longmire, CEO of Medable

Remote Patient Monitoring:
DCT Connected Devices

See real-time patient outcome updates
Provide context with quality of life data
Configure intelligent real-time alerts
Learn More
Trusted by
Why Medable?
1M
Over 1 million patients on platform
>90%
>90% patient app satisfaction
85+
85+ studies across 41+ countries
10-14w
Accelerated Deployment of 10-14 weeks